Q8C863 (ITCH_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 110.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: E3 ubiquitin-protein ligase Itchy EC=6.3.2.- | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 864 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Acts as an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. It catalyzes 'Lys-29'-, 'Lys-48'- and 'Lys-63'-linked ubiquitin conjugation. It is involved in the control of inflammatory signaling pathways. Is an essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, TAX1BP1 and RNF11, that ensures the transient nature of inflammatory signaling pathways. Promotes the association of the complex after TNF stimulation. Once the complex is formed, TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NFKB1 By similarity. Ubiquitinates RIPK2 by 'Lys-63'-linked conjugation and influences NOD2-dependent signal transduction pathways By similarity. Regulates the transcriptional activity of several transcription factors involved in immune response. Critical regulator of T-helper (TH2) cytokine development through its ability to induce JUNB ubiquitination and degradation. Ubiquitinates SNX9 By similarity. Ubiquitinates CXCR4 and HGS/HRS and regulates sorting of CXCR4 to the degradative pathway By similarity. It is involved in the negative regulation of MAVS-dependent cellular antiviral responses. Ubiquitinates MAVS through 'Lys-48'-linked conjugation resulting in MAVS proteasomal degradation By similarity. Involved in the regulation of apoptosis and reactive oxygen species levels through the ubiquitination and proteasomal degradation of TXNIP By similarity. Mediates the antiapoptotic activity of epidermal growth factor through the ubiquitination and proteasomal degradation of p15 BID. Targets DTX1 for lysosomal degradation and controls NOTCH1 degradation, in the absence of ligand, through 'Lys-29'-linked polyubiquitination By similarity. Ref.5 Ref.8 Ref.11 Ref.12 Ref.13 |
| Enzyme regulation | Activated by NDFIP1- and NDFIP2-binding By similarity. |
| Pathway | |
| Subunit structure | Monomer By similarity. Interacts with (via its WW domains) with ATN1. Interacts with ARHGEF7 and RNF11. Interacts (via the WW 1 domain) with NFE2 (via the PXY motif 1); the interaction promotes 'Lys-63'-linked ubiquitination of NFE2, retains it in the cytoplasm and prevents its transactivation activity. Interacts (via WW domain 2) with N4BP1; leading to inhibits its E3 ubiquitin-protein ligase activity. Interacts (via WW domains) with CXCR4 (via C-terminus); the interaction depends on CXCR4 phosphorylation. Interacts (via WW domains) with PCBP2 within a complex containing ITCH, MAVS and PCBP2. Interacts with FYN; the interaction phosphorylates ITCH on Tyr-381 decreasing binding of JUNB. Interacts (via WW domains) with TXNIP (via C-terminus). Interacts with ERBB4, DTX1, SPG20, SNX9 and SNX18. Interacts with OTUD7B By similarity. Interacts (via its WW domains) with OCNL, NOTCH1, JUN and JUNB. Interacts with p15 BID and MAPK8. Interacts with NDFIP1 and NDFIP2; the interaction with NDFIP proteins activates the E3 ubiquitin-protein ligase and may induce its recruitment to exosomes. Interacts (via WW domain 2) with N4BP1; the interaction inhibits the E3 ubiquitin-protein ligase activity. Interacts (via WW domains) with SGK3. Ref.4 Ref.5 Ref.6 Ref.7 Ref.9 Ref.10 Ref.11 Ref.13 |
| Subcellular location | Cell membrane By similarity. Cytoplasm. Nucleus. Note: Associates with endocytic vesicles By similarity. May be recruited to exosomes by NDFIP1 By similarity. |
| Tissue specificity | Widely expressed. |
| Post-translational modification | On T-cell activation, phosphorylation by the JNK cascade on serine and threonine residues surrounding the PRR domain accelerates the ubiquitination and degradation of JUN and JUNB. The increased ITCH catalytic activity due to phosphorylation by JNK1 may occur due to a conformational change disrupting the interaction between the PRR/WW motifs domain and the HECT domain and, thus exposing the HECT domain. Phosphorylation by FYN reduces interaction with JUNB and negatively controls JUN ubiquitination and degradation. Ubiquitinated; autopolyubiquitination with 'Lys-63' linkages which does not lead to protein degradation By similarity. Ref.8 Ref.10 Ref.12 Ref.13 |
| Involvement in disease | Defects in Itch are the cause of the itchy phenotype which is an inflammatory and immunological condition characterized by inflammation in the lung and stomach, hyperplasia in lymphoid and hematopoietic cells and constant itching in the skin. Ref.1 |
| Sequence similarities | Contains 1 C2 domain. Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain. Contains 4 WW domains. |
| Caution | It is uncertain whether Met-1 or Met-11 is the initiator. |
| Sequence caution | The sequence AAB99764.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8C863-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Major form. | ||||||
| Isoform 2 (identifier: Q8C863-2) The sequence of this isoform differs from the canonical sequence as follows: 742-759: LLCGMQEIDLNDWQRHAI → MNFYLLKHTSKYSFRYLF 760-864: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||
Molecule processing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 864 | 864 | E3 ubiquitin-protein ligase Itchy | PRO_0000120318 | |||||||||||||||
Regions | |||||||||||||||||||
| Domain | 5 – 99 | 95 | C2 | ||||||||||||||||
| Domain | 287 – 320 | 34 | WW 1 | ||||||||||||||||
| Domain | 319 – 352 | 34 | WW 2 | ||||||||||||||||
| Domain | 399 – 432 | 34 | WW 3 | ||||||||||||||||
| Domain | 439 – 472 | 34 | WW 4 | ||||||||||||||||
| Domain | 530 – 864 | 335 | HECT | ||||||||||||||||
| Region | 356 – 432 | 77 | Required for interaction with FYN By similarity | ||||||||||||||||
| Region | 535 – 544 | 10 | MAP kinase docking site | ||||||||||||||||
| Compositional bias | 211 – 226 | 16 | Arg/Pro-rich (PRR domain) | ||||||||||||||||
Sites | |||||||||||||||||||
| Active site | 832 | 1 | Glycyl thioester intermediate By similarity | ||||||||||||||||
Amino acid modifications | |||||||||||||||||||
| Modified residue | 199 | 1 | Phosphoserine; by MAPK8 Ref.10 | ||||||||||||||||
| Modified residue | 222 | 1 | Phosphothreonine; by MAPK8 Ref.10 | ||||||||||||||||
| Modified residue | 232 | 1 | Phosphoserine; by MAPK8 Ref.10 | ||||||||||||||||
| Modified residue | 346 | 1 | Phosphothreonine; by SGK3 By similarity | ||||||||||||||||
| Modified residue | 381 | 1 | Phosphotyrosine; by FYN By similarity | ||||||||||||||||
| Modified residue | 411 | 1 | Phosphoserine; by SGK3 By similarity | ||||||||||||||||
Natural variations | |||||||||||||||||||
| Alternative sequence | 742 – 759 | 18 | LLCGM…QRHAI → MNFYLLKHTSKYSFRYLF in isoform 2. | VSP_008452 | |||||||||||||||
| Alternative sequence | 760 – 864 | 105 | Missing in isoform 2. | VSP_008453 | |||||||||||||||
Experimental info | |||||||||||||||||||
| Mutagenesis | 199 | 1 | S → A: No loss of MAPK8-mediated phosphorylation and no effect on ligase activity. Almost complete inactivation of ligase activity; when associated with A-232. Greatly reduced MAPK8-mediated phosphorylation; when associated with A-222 or A-232. Completely abolishes MAPK8-mediated phosphorylation; when associated with A-222 and A-232. Ref.10 | ||||||||||||||||
| Mutagenesis | 199 | 1 | S → D: More sensitive to in vitro proteolysis. Ref.10 | ||||||||||||||||
| Mutagenesis | 222 | 1 | T → A: No loss of MAPK8-mediated phosphorylation. Greatly reduced MAPK8-mediated phosphorylation; when associated with A-199 or A-232. Completely abolishes MAPK8-mediated phosphorylation; when associated with A-199 and A-232. Ref.10 | ||||||||||||||||
| Mutagenesis | 222 | 1 | T → D: Inhibits in vitro interaction between ITCH HECT domain and PRR/WW motifs. More sensitive to in vitro proteolysis. Ref.10 | ||||||||||||||||
| Mutagenesis | 232 | 1 | S → A: No loss of MAPK8-mediated phosphorylation and no effect on ligase activity. Almost complete inactivation of ligase activity; when associated with A-199. Greatly reduced MAPK8-mediated phosphorylation; when associated with A-199 or A-222. Completely abolishes MAPK8-mediated phosphorylation; when associated with A-199 and A-222. Ref.10 | ||||||||||||||||
| Mutagenesis | 232 | 1 | S → D: More sensitive to in vitro proteolysis. Ref.10 | ||||||||||||||||
| Mutagenesis | 535 – 540 | 6 | RRRLWV → AAALWA: Abolishes interaction with MAPK8. Ref.10 | ||||||||||||||||
| Mutagenesis | 535 – 537 | 3 | RRR → AAA: Almost complete loss of interaction with MAPK8. | ||||||||||||||||
| Mutagenesis | 535 – 536 | 2 | RR → AA: Greatly decreased interaction with MAPK8 and ligase activity. | ||||||||||||||||
| Mutagenesis | 832 | 1 | C → A: Loss of ubiquitin protein ligase activity. Ref.6 | ||||||||||||||||
Secondary structure | |||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||
| Beta strand | 399 – 401 | 3 | |||||||||||||||||
| Beta strand | 407 – 409 | 3 | |||||||||||||||||
| Beta strand | 411 – 413 | 3 | |||||||||||||||||
| Beta strand | 415 – 419 | 5 | |||||||||||||||||
| Turn | 420 – 423 | 4 | |||||||||||||||||
| Beta strand | 424 – 426 | 3 | |||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice." Perry W.L., Hustad C.M., Swing D.A., O'Sullivan T.N., Jenkins N.A., Copeland N.G. Nat. Genet. 18:143-146(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DISEASE. Strain: C3H/HeJ. Tissue: Kidney. |
| [2] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Strain: C57BL/6J. Tissue: Head. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Strain: C57BL/6. Tissue: Brain. |
| [4] | "N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein." Harvey K.F., Shearwin-Whyatt L.M., Fotia A., Parton R.G., Kumar S. J. Biol. Chem. 277:9307-9317(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NDFIP1. |
| [5] | "Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation." Fang D., Elly C., Gao B., Fang N., Altman Y., Joazeiro C., Hunter T., Copeland N.G., Jenkins N.A., Liu Y.C. Nat. Immunol. 3:281-287(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH JUN AND JUNB. |
| [6] | "Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase." Qiu L., Joazeiro C., Fang N., Wang H.-Y., Elly C., Altman Y., Fang D., Hunter T., Liu Y.-C. J. Biol. Chem. 275:35734-35737(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NOTCH1, MUTAGENESIS OF CYS-832. |
| [7] | "The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch." Traweger A., Fang D., Liu Y.-C., Stelzhammer W., Krizbai I.A., Fresser F., Bauer H.-C., Bauer H. J. Biol. Chem. 277:10201-10208(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH OCNL. |
| [8] | "Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch." Gao M., Labuda T., Xia Y., Gallagher E., Fang D., Liu Y.C., Karin M. Science 306:271-275(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION, FUNCTION, AUTOUBIQUITINATION. |
| [9] | "Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation." Oliver P.M., Cao X., Worthen G.S., Shi P., Briones N., MacLeod M., White J., Kirby P., Kappler J., Marrack P., Yang B. Immunity 25:929-940(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NDFIP1. |
| [10] | "Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change." Gallagher E., Gao M., Liu Y.C., Karin M. Proc. Natl. Acad. Sci. U.S.A. 103:1717-1722(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-199; THR-222 AND SER-232, INTERACTION WITH MAPK8, AUTOUBIQUITINATION, SUBUNIT, MUTAGENESIS OF SER-199; THR-222; SER-232 AND 535-ARG--VAL-540. |
| [11] | "The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch." Oberst A., Malatesta M., Aqeilan R.I., Rossi M., Salomoni P., Murillas R., Sharma P., Kuehn M.R., Oren M., Croce C.M., Bernassola F., Melino G. Proc. Natl. Acad. Sci. U.S.A. 104:11280-11285(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH N4BP1. |
| [12] | "AIP4/Itch regulates Notch receptor degradation in the absence of ligand." Chastagner P., Israel A., Brou C. PLoS ONE 3:E2735-E2735(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, UBIQUITINATION OF NOTCH1. |
| [13] | "The ubiquitin ligase Itch mediates the antiapoptotic activity of epidermal growth factor by promoting the ubiquitylation and degradation of the truncated C-terminal portion of Bid." Azakir B.A., Desrochers G., Angers A. FEBS J. 277:1319-1330(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH P15 BID, UBIQUITINATION OF P15 BID. |
| [14] | "Phosphorylation of either Ser16 or Thr30 does not disrupt the structure of the Itch E3 ubiquitin ligase third WW domain." Shaw A.Z., Martin-Malpartida P., Morales B., Yraola F., Royo M., Macias M.J. Proteins 60:558-560(2005) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 399-432 OF WILD TYPE AND IN VITRO WW3-PHOSPHORYLATED FORMS. |
| [15] | "NMR structural studies of the ItchWW3 domain reveal that phosphorylation at T30 inhibits the interaction with PPxY-containing ligands." Morales B., Ramirez-Espain X., Shaw A.Z., Martin-Malpartida P., Yraola F., Sanchez-Tillo E., Farrera C., Celada A., Royo M., Macias M.J. Structure 15:473-483(2007) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 399-432 OF WILD TYPE AND IN VITRO PHOSPHORYLATED FORMS IN COMPLEX WITH PPXY MOTIFS OF EPSTEIN-BARR VIRUS LMP2A. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF037454 mRNA. Translation: AAB99764.1. Different initiation. AK048303 mRNA. Translation: BAC33298.1. BC062934 mRNA. Translation: AAH62934.1. | ||||||||||||||||||||||||
| IPI | IPI00380162. IPI00380163. | ||||||||||||||||||||||||
| RefSeq | NP_001230641.1. NM_001243712.1. NP_032421.2. NM_008395.3. | ||||||||||||||||||||||||
| UniGene | Mm.208286. Mm.490088. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | Q8C863. | ||||||||||||||||||||||||
| SMR | Q8C863. Positions 13-145, 287-858. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-29318N. | ||||||||||||||||||||||||
| IntAct | Q8C863. 8 interactions. | ||||||||||||||||||||||||
| MINT | MINT-142559. | ||||||||||||||||||||||||
| STRING | 10090.ENSMUSP00000105307. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q8C863. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | Q8C863. | ||||||||||||||||||||||||
| PRIDE | Q8C863. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSMUST00000029126; ENSMUSP00000029126; ENSMUSG00000027598. ENSMUST00000109685; ENSMUSP00000105307; ENSMUSG00000027598. | ||||||||||||||||||||||||
| GeneID | 16396. | ||||||||||||||||||||||||
| KEGG | mmu:16396. | ||||||||||||||||||||||||
| UCSC | uc008nkd.1. mouse. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 83737. | ||||||||||||||||||||||||
| MGI | MGI:1202301. Itch. | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | COG5021. | ||||||||||||||||||||||||
| GeneTree | ENSGT00570000078756. | ||||||||||||||||||||||||
| HOVERGEN | HBG004134. | ||||||||||||||||||||||||
| InParanoid | Q8C863. | ||||||||||||||||||||||||
| KO | K05632. | ||||||||||||||||||||||||
| OMA | PTETIGD. | ||||||||||||||||||||||||
| OrthoDB | EOG47H5PD. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_115202. Signal Transduction. | ||||||||||||||||||||||||
| UniPathway | UPA00143. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q8C863. | ||||||||||||||||||||||||
| Bgee | Q8C863. | ||||||||||||||||||||||||
| CleanEx | MM_ITCH. | ||||||||||||||||||||||||
| Genevestigator | Q8C863. | ||||||||||||||||||||||||
| GermOnline | ENSMUSG00000027598. Mus musculus. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR000008. C2_Ca-dep. IPR008973. C2_Ca/lipid-bd_dom_CaLB. IPR018029. C2_membr_targeting. IPR024928. E3_ub_ligase_SMURF1. IPR000569. HECT. IPR001202. WW_dom. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00168. C2. 1 hit. PF00632. HECT. 1 hit. PF00397. WW. 4 hits. [Graphical view] | ||||||||||||||||||||||||
| PIRSF | PIRSF001569. E3_ub_ligase_SMURF1. 1 hit. | ||||||||||||||||||||||||
| SMART | SM00239. C2. 1 hit. SM00119. HECTc. 1 hit. SM00456. WW. 4 hits. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF49562. C2_CaLB. 1 hit. SSF56204. HECT. 1 hit. SSF51045. WW_Rsp5_WWP. 4 hits. | ||||||||||||||||||||||||
| PROSITE | PS50004. C2. 1 hit. PS50237. HECT. 1 hit. PS01159. WW_DOMAIN_1. 4 hits. PS50020. WW_DOMAIN_2. 4 hits. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChiTaRS | ITCH. mouse. | ||||||||||||||||||||||||
| EvolutionaryTrace | Q8C863. | ||||||||||||||||||||||||
| NextBio | 289541. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | ITCH_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q8C863 Secondary accession number(s): O54971 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
